Omos Bio Making pre-cancer treatable
1 known investors
Find your way into Omos Bio Making pre-cancer treatable
449 people in our graph share verified history with the Omos Bio Making pre-cancer treatable team — schools, employers, funds. One of them is your warm intro.
Mariaunlockedknows Thomas Caganek · together at University of Oxford (overlapped)
×6knows the team · via University of Oxford
×4knows the team · via Imperial College London
knows the team · via Oxford Entrepreneurs
Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.
Founders & leadership
FH
Frederik Heymann LasseninFounder
TC
Thomas CaganekinFounderThomas Caganek is a medical doctor trained at Oxford who founded Omos Biosciences, which develops molecular diagnostic tools for analyzing pre-cancer signatures to identify high-risk cases.
Investors · 1
Frequently asked questions
- What does Omos Bio Making pre-cancer treatable do?
- Omos Biosciences develops molecular diagnostic tools that analyze the molecular signatures of pre-cancers to identify which cases are high risk and require intervention. The technology is aimed at helping clinicians with treatment stratification to reduce over-treatment and enable early cancer intervention.
- Who founded Omos Bio Making pre-cancer treatable?
- Omos Bio Making pre-cancer treatable was founded by Frederik Heymann Lassen, Thomas Caganek.
- Who are Omos Bio Making pre-cancer treatable's investors?
- Omos Bio Making pre-cancer treatable's investors include Spacecadet Ventures.